M
Maryza Graham
Researcher at University of Melbourne
Publications - 6
Citations - 37
Maryza Graham is an academic researcher from University of Melbourne. The author has contributed to research in topics: Medicine & Coronavirus. The author has an hindex of 2, co-authored 6 publications receiving 11 citations.
Papers
More filters
Journal ArticleDOI
Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay.
Maryza Graham,Eloise Williams,Nicole Isles,Eka Buadromo,Tebuka Toatu,Julian Druce,Mike Catton,Chantel Lin,Benjamin P Howden,Deborah A Williamson +9 more
TL;DR: Evaluating the performance of Cepheid Xpert® Xpress SARS-CoV-2 RT-PCR assay for testing samples in pools of four and six finds pooling of four or six samples may be an effective strategy to increase testing capacity.
Journal ArticleDOI
Use of emerging testing technologies and approaches for SARS-CoV-2: review of literature and global experience in an Australian context.
Maryza Graham,Susan A Ballard,Shivani Pasricha,Belinda Lin,Tuyet Hoang,Timothy P. Stinear,Julian Druce,Mike Catton,Norelle L Sherry,Deborah A Williamson,Benjamin P Howden +10 more
TL;DR: In this paper, the authors present a review of emerging testing technologies for detection of SARS-CoV-2, including those that are rapid and can be used at point-of-care (POC), and those facilitating high throughput laboratory-based testing.
Journal ArticleDOI
Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection.
Katherine Bond,Katherine Bond,Eloise Williams,Suellen Nicholson,S Lim,S Lim,Douglas F Johnson,Douglas F Johnson,B Cox,Mark Putland,Emma Gardiner,E Tippett,Maryza Graham,Francesca L Mordant,Michael G Catton,Sharon R Lewin,Sharon R Lewin,Kanta Subbarao,Benjamin P Howden,Deborah A Williamson +19 more
TL;DR: In this paper, the authors evaluated the performance of three serology assays for SARS-CoV-2 infection, including Abbott, DiaSorin, and Roche, using 217 serum samples from 131 participants up to 7 months following COVID-19 infection.
Journal ArticleDOI
Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting.
Maryza Graham,Stephen Muhi,Tuyet Hoang,Susan A Ballard,Julie L. McAuley,Jason C Kwong,Deborah A Williamson,Benjamin P Howden +7 more
Journal ArticleDOI
Viral Genomics to Inform Infection-control Response in Occupational Coronavirus Disease 2019 (COVID-19) Transmission.
Naomi C A Whyler,Norelle L Sherry,Courtney R Lane,Torsten Seemann,Patiyan Andersson,Michelle Sait,Maryza Graham,Tony M. Korman,Benjamin P Howden,Rhonda L. Stuart +9 more
TL;DR: Two instances of healthcare workers contracting SARS-CoV-2 despite no known breach of personal protective equipment were reported, and viral genomic sequencing supported this transmission hypothesis and the subsequent response.